Robotic Focal HIFU: Treatment Options
No surgery. No cutting. No radiation.
Prostate cancer remains the most common cancer amongst men in the US (2023)
288,300
New Cases Diagnosed Every Year in the US (1)
34,700
Deaths every year in the US (1)
1 Million
Prostate Biopsies Performed Annually in the
US and Increasing Every Year(2)
3.1 Million
American Men Living with Prostate Cancer(1)
* 2022 estimates from American Cancer Society (www.cancer.org)
Prostate Specific Antigen (PSA) What Is It?
PSA – What Is It?
What is PSA
A PSA is a protein produced by tissue in the prostate.
PSA Tests
A PSA test is a blood test used primarily to screen for prostate cancer. It measures the amount of prostate specific antigen in the blood.
A PSA test can detect high levels of PSA which may indicate the presence of prostate cancer.
There are other conditions that can be affiliated to an elevated PSA like an enlarged or inflamed prostate.
Elevated PSA | Next Steps
Prostate MRI:
Magnetic resonance imaging (MRI) uses a magnetic field, radiofrequency pulses, and a computer to produce detailed pictures of the body. A Prostate MRI is used to evaluate the extent of prostate cancer.
Genomic Test:
Genomic testing is done on cancerous tissue taken from the prostate in order to provide information about how your prostate cancer might behave in addition to determining a treatment pathway.
Prostate Biopsy:
A procedure that tests and removes samples of suspicious tissue from the prostate.
Prostate Cancer Treatment Options
Radical Surgery vs. Organ-Sparing Treatments
The Trend Toward Organ Preserving Cancer Treatments
Focal Therapy Fills an Important Treatment Gap in the Management of Prostate Cancer
High Intensity Focused Ultrasound (HIFU) What Is It?
High Intensity Focused Ultrasound (HIFU)
Robotic HIFU is a non-invasive procedure, which means there is no surgery, no cutting, no radiation. This treatment minimizes the impact on critical neighboring structures such as the urinary sphincter and erectile nerves. Unlike radical treatments such as surgery or radiation that affect the whole gland and may damage surrounding tissue and structures. Focal Robotic HIFU precisely targets on the
desired part of the gland.
Only Platform Specifically Designed for Focal Ablation of Prostate
Focal One Patient Video
Advantages of HIFU
Non-Invasive
There is no incision, no blade, no scar, and no radiation in this treatment.
Quality of Life
Patients will be back to their day-to-day, regular activities shortly after the procedure.
Outpatient Procedure
Patients will go home in the same day.
Minimal Side Effects
There is a low risk of side effects such as incontinence and erectile dysfunction.
Who is Suitable for Treatment?
Patient Selection
Patient with Low to Intermediate Grade Cancers:
3 + 3 = 6
3 + 4 = 7
4 + 3 = 7
Patient Considerations:
• Size
• Weight
• Lesion Location
• Prior Procedures or
History: Rectal Stenosis,
Inflammation, etc.
Patient Alerts:
• Latex Allergies
• Calcifications
• Anesthesia
Treatment Day
What to expect on the day of your HIFU procedure?
• The patient arrives the morning of the treatment, and will have completed a bowel
prep the night before.
• The patient is administered general anesthesia.
• The treating Urologist will do the procedure with the Focal One system with
precision and accuracy, ablating only the targeted tissue.
• Typically, the patient is discharged shortly after the procedure with a Foley catheter.
What Happens After Treatment?
After HIFU Treatment
• At the end of the procedure, a temporary urinary catheter
will be placed. You will be discharged and can return home.
• Catheter will be removed at the first follow-up visit a few
days later (5-7 days).
• Typical follow-up will include PSA testing at three months, six
months, and one year, as well as an MRI image.
• Follow-up can be performed by the treating urologist, or your
local urologist (if you traveled for the treatment).
Clinical Data
Focal Therapy - Strong Clinical Evidence
Conclusion
• No scar, no blood loss, no radiation
• A non-invasive option for well-selected patients
• Fills an existing gap between Active Surveillance and Radical WholeGland Therapies
• Promising oncological data
• Excellent Medicare and Commercial insurance coverage
• New generation of Robotic HIFU platform provides precision, ease-ofuse and shorter procedure times
